** Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada

Similar to the US arrangement, Ocugen will retain 45 per cent of the profit from sales of Covaxin in Canada.

Ocugen Inc, the US partner for Bharat Biotech’s COVID-19 vaccine has announced the payment of $15 million upfront to the Indian drug maker for extending the vaccine rights to Canada.

Ocugen in a regulatory filing said it has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in the North American country.

** Battle against COVID: ISRO develops three types of ventilators, to transfer technology

Low-cost and portable critical care ventilator ‘PRANA’ (Programmable Respiratory Assistance for the Needy Aid) is based on the automated compression of an AMBU (Artificial Manual Breathing unit) bag

** Explained: How the US will recover remains of 400 of its soldiers missing in India

Gandhinagar-based National Forensic Sciences University has tied up with US’s Department of Defense to recover and identify the remains of over 400 missing US military personnel in India during World War II. How will they go about doing so?

** Tracing the overlapping lives of my great-grandfather and one of the heroes of the Bombay Plague

Dr Miguel Caetano Dias and Dr Acacio Gabriel Viegas had a lot in common, not least their zealous effort to save lives during the Bubonic plague.

Maybe some of you have heard of Dr Acacio Gabriel Viegas (April 1, 1856-February 21, 1933). I hadn’t until about a decade ago. Until then, I would pass by his statue near Mumbai’s Metro cinema without realising that it was his discovery of the outbreak of bubonic plague in Bombay that saved thousands of souls.

** Pfizer donates $70 mn worth COVID-19 treatment drugs to India

“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla

Global pharma major Pfizer is sending its medicines worth $70 million (over ₹510 crore), from its distribution centres in the U.S., Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on May 3.

** Andhra Pradesh Govt. nod for ‘Anandaiah preparation’, excluding eye drops

AYUSH chief says the concoction is not an ayurvedic medicine

The State government on Monday permitted the usage of the herbal preparation being given to COVID patients by B. Anandaiah, an ayurvedic practitioner of Krishnapatnam in Nellore district, by taking into account the findings of the Central Council for Research in Ayurvedic Sciences, but kept on hold its decision on the eye drops claimed to be life saving for those with dangerously low levels of oxygen.

While giving the green signal to the herbal preparation, the government warned that COVID patients should not stop taking the drugs prescribed by doctors in the normal course.

** New geometrical lines discovered in Thar Desert

The authors also suggest that the lines could be contemporary with the neighbouring memorial stones

Using Google Earth images, drone observations and field visits, two independent researchers from France have identified eight sites around Jaisalmer in the Thar Desert, that show linear features resembling geoglyphs. Geoglyphs are large, un-explained geometrical patterns on land usually proposed to be man-made features.